ANTIVIRAL TREATMENT REDUCES HEPATOCELLULAR CARCINOMA RISK IN NON-CIRRHOTIC, HBEAG-NEGATIVE CHRONIC HEPATITIS B WITH HIGH VIRAL LOAD

被引：0
|
作者：
Choi, Won-Mook [1 ]
Kim, Gi-Ae [2 ]
Choi, Gwang Hyeon [1 ,3 ,4 ]
Choi, Jonggi
Lee, Yun Bin [3 ,4 ]
Sinn, Dong Hyun
Lim, Young-Suk [1 ,5 ]
机构：
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Gastroenterol,Liver Ctr, Seoul, South Korea
[2] Kyung Hee Univ Hosp, Dept Internal Med, Seoul, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Liver Res Inst, Seoul, South Korea
[5] Sungkyunkwan Univ, Sch Med, Dept Med, Samsung Med Ctr, Seoul, South Korea
来源：
HEPATOLOGY | 2022年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1137
引用
收藏
页码：S263 / S264
页数：2
相关论文
共 50 条
  • [41] Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis
    Libbrecht, L
    Craninx, M
    Nevens, F
    Desmet, V
    Roskams, T
    HISTOPATHOLOGY, 2001, 39 (01) : 66 - 73
  • [42] Treatment paradigms in hepatitis B e antigen negative (HBeAg-negative) chronic hepatitis B patients
    Hadziyannis, S. J.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S15 - S15
  • [43] Antiviral therapy leads to histological improvement in HBeAg-negative chronic hepatitis B patients
    Basyigit, Sebahat
    Sapmaz, Ferdane
    Yeniova, Abdullah O.
    ANNALS OF GASTROENTEROLOGY, 2015, 28 (04): : 506 - +
  • [44] Treatment of HBeAg-negative chronic hepatitis B with interferon or pegylated interferon
    Brunetto, MR
    Oliveri, F
    Colombatto, P
    Coco, B
    Ciccorossi, P
    Bonino, F
    JOURNAL OF HEPATOLOGY, 2003, 39 : S164 - S167
  • [45] Viral and immune factors associated with successful treatment withdrawal in HBeAg-negative chronic hepatitis B patients
    Garcia-Lopez, Mireia
    Lens, Sabela
    Pallett, Laura J.
    Testoni, Barbara
    Rodriguez-Tajes, Sergio
    Marino, Zoe
    Bartres, Concepcion
    Garcia-Pras, Ester
    Leonel, Thais
    Perpinan, Elena
    Lozano, Juan Jose
    Rodriguez-Frias, Francisco
    Koutsoudakis, George
    Zoulim, Fabien
    Maini, Mala K.
    Forns, Xavier
    Perez-del-Pulgar, Sofia
    JOURNAL OF HEPATOLOGY, 2021, 74 (05) : 1064 - 1074
  • [46] Similarly low risk of hepatocellular carcinoma and cirrhotic complications in patients in the HBeAg-negative indeterminate phase compared with chronic infection
    Hui, Vicki Wing-Ki
    Yip, Terry Cheuk-Fung
    Tse, Yee-Kit
    Lai, Jimmy Che-To
    Chan, Henry L. Y.
    Wong, Vincent Wai-Sun
    Wong, Grace Lai-Hung
    JOURNAL OF HEPATOLOGY, 2024, 80 : S770 - S770
  • [47] Hepatocellular Carcinoma Surveillance Rates in Non-Cirrhotic Patients with Chronic Hepatitis B in the United States
    Goldberg, David S.
    Valderama, Adriana
    Kamalakar, Rajesh
    Sansgiry, Sujit S.
    Babajanyan, Svetlana
    Lewis, James D.
    HEPATOLOGY, 2014, 60 : 991A - 991A
  • [48] Antiviral therapy and risk for hepatocellular carcinoma in chronic viral hepatitis
    Abdurakhmanov, D. T.
    TERAPEVTICHESKII ARKHIV, 2013, 85 (10) : 94 - 97
  • [49] Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B
    Choi, Won-Mook
    Kim, Gi-Ae
    Choi, Jonggi
    Choi, Gwang Hyeon
    Lee, Yun Bin
    Sinn, Dong Hyun
    Lim, Young-Suk
    GUT, 2024, 73 (04) : 649 - 658
  • [50] HEPATITIS B VERSUS HEPATITIS B DELTA CO-INFECTION AND RISK OF HEPATOCELLULAR CARCINOMA IN NON-CIRRHOTIC LIVER
    Amakye, Dominic
    Mbakop, Raissa Nana Sede
    Olaosebikan, Kikelomo
    Soladoye, Elizabeth
    Moparty, Hamsika
    Forlemu, Arnold
    Bandaru, Praneeth K.
    Lohani, Sweta
    Kavuri, Swathi
    Garzon-Siatoya, Wendy Tatiana
    Ronda, Vishnu Poojitha
    Garlapati, Pavani
    Gayam, Vijay
    Wakil, Ali
    Etienne, Denzil
    Reddy, Madhavi
    GASTROENTEROLOGY, 2024, 166 (05) : S1053 - S1054
12345